Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Sartorius Stedim Biotech
  6. Summary
    DIM   FR0013154002

SARTORIUS STEDIM BIOTECH

(DIM)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Real-time Quote. Real-time Euronext Paris
10/18/2021 10/19/2021 10/20/2021 10/21/2021 10/22/2021 Date
471.6(c) 471.3(c) 469.3(c) 483.2(c) 479(c) Last
27 682 56 348 63 219 48 873 27 512 Volume
+0.81% -0.06% -0.42% +2.96% -0.87% Change
More quotes
Estimated financial data (e)
Sales 2021 2 860 M 3 330 M 3 330 M
Net income 2021 598 M 696 M 696 M
Net Debt 2021 591 M 689 M 689 M
P/E ratio 2021 73,8x
Yield 2021 0,28%
Sales 2022 3 219 M 3 748 M 3 748 M
Net income 2022 650 M 756 M 756 M
Net Debt 2022 280 M 326 M 326 M
P/E ratio 2022 69,2x
Yield 2022 0,36%
Capitalization 44 154 M 51 360 M 51 409 M
EV / Sales 2021 15,6x
EV / Sales 2022 13,8x
Nbr of Employees 9 619
Free-Float 26,2%
More Financials
Company
Sartorius Stedim Biotech SA is a France-based international provider of laboratory and process technologies and equipment. The Company covers the segments of biotechnology and mechatronics. Sartorius provides services which help customers to implement complex and quality-critical processes in biopharmaceutical production and laboratory environments in a time- and cost-efficient way. The Company’s customers are... 
More about the company
Ratings of Sartorius Stedim Biotech
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about SARTORIUS STEDIM BIOTECH
10/21CHA BIOTECH : Unit Signs Contract with Sartorius for Viral Vectors Process Technology
MT
10/20GLOBAL MARKETS LIVE : Kering, Netflix, Roche, United Airlines, Xiaomi...
10/20PRESS RELEASE : Curexsys Appoints Christian Eckert as Chief Operating Officer
DJ
10/20SARTORIUS STEDIM BIOTECH : Q3 Profit Soars On Significant Demand Momentum
MT
10/20SARTORIUS' : Nine-Month Profit Soars Almost 93% On Strong Revenue Growth
MT
10/20SARTORIUS STEDIM BIOTECH : Earnings Release 9M|2021
PU
10/20SARTORIUS STEDIM BIOTECH : grows dynamically and profitably – Substantial...
PU
10/20SARTORIUS STEDIM BIOTECH : Nine-month results of Sartorius Stedim Biotech
PR
10/13SARTORIUS : Heir Agrees on Changes to Joint Heirship
MT
10/13SARTORIUS AG : Release according to Article 40, Section 1 of the WpHG [the German Securiti..
DJ
10/08VIDEO : This week's gainers and losers
10/04SARTORIUS STEDIM BIOTECH SA : Declaration relative to the number of shares and voting righ..
DJ
10/04SARTORIUS STEDIM BIOTECH SA : Declaration relative au nombre d'actions et de droits de vot..
DJ
10/01ANALYST RECOMMENDATIONS : Acceleron Pharma, General Mills, Southwest Airlines, Home Depot,..
09/27SARTORIUS : To Open New Plant In Michigan, US
MT
More news
News in other languages on SARTORIUS STEDIM BIOTECH
10/21AKTIEN FRANKFURT SCHLUSS : Dax gibt nach - Verluste bei SAP belasten
10/21XETRA-SCHLUSS/Etwas leichter - SAP unter Druck
10/21AKTIEN FRANKFURT : Dax findet den Weg ins Plus - Software-Aktien gefragt
10/21AKTIEN FRANKFURT : Dax stabilisiert sich - Software-Aktien gefragt
10/21Sartorius knüpfen an späte Erholung vom Vortag an
More news
Analyst Recommendations on SARTORIUS STEDIM BIOTECH
More recommendations
Stock Trading Strategies
SARTORIUS STEDIM BIOTECH - 07/06
Close to a key resistance level
BUY
More Stock Trading Analysis
Chart SARTORIUS STEDIM BIOTECH
Duration : Period :
Sartorius Stedim Biotech Technical Analysis Chart | DIM | FR0013154002 | MarketScreener
Technical analysis trends SARTORIUS STEDIM BIOTECH
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 479,00 €
Average target price 458,00 €
Spread / Average Target -4,38%
EPS Revisions
Managers and Directors
Joachim Kreuzburg Chairman & Chief Executive Officer
Oscar-Werner Reif Executive VP-Research & Development
Volker Niebel Executive VP-Operations & Information Technology
Henri Riey Independent Non-Executive Director
Anne-Marie Graffin Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
SARTORIUS STEDIM BIOTECH64.49%51 360
ABBOTT LABORATORIES15.74%224 651
MEDTRONIC PLC5.08%165 656
BECTON, DICKINSON AND COMPANY-1.25%70 962
HOYA CORPORATION21.65%56 316
DEXCOM, INC.53.24%54 815